KR950703347A - 이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate) - Google Patents

이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate) Download PDF

Info

Publication number
KR950703347A
KR950703347A KR1019950701166A KR19950701166A KR950703347A KR 950703347 A KR950703347 A KR 950703347A KR 1019950701166 A KR1019950701166 A KR 1019950701166A KR 19950701166 A KR19950701166 A KR 19950701166A KR 950703347 A KR950703347 A KR 950703347A
Authority
KR
South Korea
Prior art keywords
inositol
triphosphate
antagonizing
oligomers
activity
Prior art date
Application number
KR1019950701166A
Other languages
English (en)
Korean (ko)
Inventor
케네쓰 에이. 스토더만
Original Assignee
스티븐 엘. 네스비트
메렐 다우 파마슈티칼스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 스티븐 엘. 네스비트, 메렐 다우 파마슈티칼스 인크. filed Critical 스티븐 엘. 네스비트
Publication of KR950703347A publication Critical patent/KR950703347A/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/795—Polymers containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
KR1019950701166A 1992-09-28 1993-08-30 이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate) KR950703347A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US95239392A 1992-09-28 1992-09-28
US07/952393 1992-09-28
PCT/US1993/008168 WO1994007507A1 (en) 1992-09-28 1993-08-30 Method for antagonizing inositol 1,4,5-triphosphate

Publications (1)

Publication Number Publication Date
KR950703347A true KR950703347A (ko) 1995-09-20

Family

ID=25492868

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950701166A KR950703347A (ko) 1992-09-28 1993-08-30 이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate)

Country Status (13)

Country Link
EP (1) EP0661982A1 (es)
JP (1) JPH08502068A (es)
KR (1) KR950703347A (es)
AU (1) AU670962B2 (es)
CA (1) CA2145681A1 (es)
HU (1) HUT70192A (es)
IL (1) IL107066A (es)
MX (1) MX9305933A (es)
NO (1) NO951163L (es)
NZ (1) NZ256178A (es)
TW (1) TW260663B (es)
WO (1) WO1994007507A1 (es)
ZA (1) ZA936978B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2978995A (en) * 1994-06-30 1996-01-25 Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. Methods for treating cell proliferative disorders by modulating signal transduction
US5780483A (en) * 1995-02-17 1998-07-14 Smithkline Beecham Corporation IL-8 receptor antagonists
WO1996025157A1 (en) 1995-02-17 1996-08-22 Smithkline Beecham Corporation Il-8 receptor antagonists
US6083920A (en) * 1995-12-21 2000-07-04 Ayurcore, Inc. Compositions for modulating intracellular inositol trisphosphate concentration
US6005008A (en) * 1996-02-16 1999-12-21 Smithkline Beecham Corporation IL-8 receptor antagonists
US6211373B1 (en) 1996-03-20 2001-04-03 Smithkline Beecham Corporation Phenyl urea antagonists of the IL-8 receptor
US6262113B1 (en) 1996-03-20 2001-07-17 Smithkline Beecham Corporation IL-8 receptor antagonists
AU3499497A (en) 1996-06-27 1998-01-14 Smithkline Beecham Corporation Il-8 receptor antagonists
TR199802694T2 (xx) * 1996-06-27 1999-03-22 Smithkline Beecham Corporation IL-8 resept�r kar��tlar�
ATE358486T1 (de) * 2000-11-09 2007-04-15 Contrimmune Biotechnology Inc Verwendung von xestospongin c zur behandlung oder vorbeugung einer hiv-infektion
CA2857374A1 (en) 2011-09-02 2013-03-07 The Trustees Of Columbia University In The City Of New York Camkii, ip3r, calcineurin, p38 and mk2/3 inhibitors to treat metabolic disturbances of obesity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB781479A (en) * 1953-08-27 1957-08-21 Ciba Ltd New polyureas and process for making them
US5276182A (en) * 1990-07-09 1994-01-04 The Dow Chemical Company Process for preparing polyurea oligomers

Also Published As

Publication number Publication date
TW260663B (es) 1995-10-21
AU4841793A (en) 1994-04-26
WO1994007507A1 (en) 1994-04-14
JPH08502068A (ja) 1996-03-05
CA2145681A1 (en) 1994-04-14
EP0661982A1 (en) 1995-07-12
NZ256178A (en) 1997-03-24
ZA936978B (en) 1994-04-18
NO951163D0 (no) 1995-03-27
MX9305933A (es) 1994-04-29
HUT70192A (en) 1995-09-28
AU670962B2 (en) 1996-08-08
NO951163L (no) 1995-03-27
IL107066A0 (en) 1993-12-28
HU9500891D0 (en) 1995-05-29
IL107066A (en) 1998-01-04

Similar Documents

Publication Publication Date Title
KR900012911A (ko) 흥분성 아미노산 수용기 길항질 화합물
RU94044671A (ru) Применение непептидных антагонистов рецептора тахикинина
ES2150489T3 (es) 1-amidinofenil-pirrolidonas, -piperidinonas, -azetinonas como inhibidores de la agregacion de plaquetas.
BR9812176A (pt) Antagonista de receptor il-8
ATE347892T1 (de) Verwendung von nmda-antagonisten zur behandlung von schmerzen
KR950703347A (ko) 이노시톨 1,4,5-트리포스페이트의 길항 방법(Method for Antagonizing Inositol 1,4,5-Triphosphate)
DE69705300T2 (de) Cyclopropylalkansäurederivate
DK0527687T3 (da) Hidtil ukendte arylethylaminderivater, fremgansmåder til fremstilling heraf og farmaceutiske midler, som indeholder dem
ES2190428T3 (es) Antagonistas biciclicos de fibrinogeno.
KR950017957A (ko) 3, 4, 4-삼치환-피페리디닐-n-알킬카르복실레이트의 제법 및 중간체
EA200000682A1 (ru) Новые ацилгуанидиновые производные в качестве ингибиторов резорбции костной ткани и антагонистов витронектиновых рецепторов
EP1918287A3 (en) LPA receptor agonists and antagonists and methods of use
MX9203775A (es) Compuestos arilicos biciclicos substituidos, que exhiben actividad antagonista al leucotrieno b4 selectiva.
KR950016725A (ko) 폐 고혈압성 질병을 억제하는 방법
NO20000466D0 (no) Farmasoeytisk preparat for sure, lipofile forbindelser i form av en selvemulgerende formulering
RU94045881A (ru) Производные пептидов, способ получения, фармацевтическая композиция, способ лечения
WO1992019211A3 (en) Imidazobenzoquinones and composition for preventing or treating hypertension or congestive heart failure containing the same
NO972623D0 (no) Framasöytisk blanding omfattende lamotrigin
ES2110115T3 (es) Inhibidores de la agregacion de plaquetas.
DE69317418T2 (de) PHARMAZEUTISCHE ZUSAMMENSETZUNGEN VON 5HT1 AGONISTISCHEN ALKYL SULPHONAMIDENFüR REKTALE VERABREICHUNGEN
NO944931L (no) Anvendelse av 2-fenyl-3-aroylbenzotiofener for inhibering av tidlig seksuell modenhet
UA37173C2 (uk) Болюс з пролонованим виділенням активного інгредієнта, спосіб захисту жуйних тварин від зараження гельмінтами, спосіб профілактики аб0 пригнічення, системного контролю зниження або запобігання зараженнь у жуйних тварин, спосіб отримання болюсів
MY104979A (en) [ 5(6)(ih-azole-1-ylmethyl) benzimidazole] carbamates.
EP0317953A3 (en) N-(1-thienylcycloalkyl)alkenylamines for treatment of neurotoxic injury
ES2046641T3 (es) Composicion antitumoral.

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application